Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SABAR: Atazanavir Switch for Endothelial Function in HIV
NCT00225017Phase 3Completed
- Sponsor
- Northwestern University
- Start
- Jun 2005
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of atazanavir in hyperlipidemia, sponsored by Northwestern University. Started Jun 2005; status: completed.
02
Drugs
atazanavir
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT00225017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225017.